Health Care Checkup

March 28, 2025

THE BIG PICTURE: KEY CONGRESSIONAL & EXECUTIVE BRANCH DEVELOPMENTS


On Thursday, the Department of Health and Human Services (HHS) announced a restructuring that will reduce its workforce by 10,000 employees, from 82,000 to 72,000 full-time employees. HHS will also consolidate the 28 divisions of HHS into 15 new divisions, including a new Administration for a Healthy America (AHA).

 

On Tuesday, the Senate confirmed Marty Makary’s nomination as commissioner of the Food and Drug Administration and Jay Bhattacharya as director of the National Institutes of Health (NIH). The Senate Finance Committee also held a markup advancing the nomination of Mehmet Oz to be Administrator of the Centers for Medicare & Medicaid Services (CMS).

 

On Monday, President Donald Trump nominated Susan Monarez, the Centers for Disease Control’s (CDC) current acting director, to serve as the next director. The decision comes after the administration pulled the first nominee, Dr. Dave Weldon, hours before his Senate confirmation hearing. 

What to Expect Next Week:



The House and Senate Republican leadership continues to work towards a compromise on a budget resolution. Majority Leader Thune has announced his intention to vote on a compromise budget resolution as early as next week. If the Senate moves forward, this will necessitate another vote-a-rama marathon session. 

 

In the House, the Energy and Commerce Committee will hold two health care hearings on Tuesday on cybersecurity vulnerabilities in legacy medical devices and over-the-counter monograph drugs. The Education and Workforce Committee will also hold a hearing on Wednesday on employer-sponsored health care.

 

On Thursday, the Senate Judiciary Committee will mark up five bills addressing pharmaceutical patent abuses and one bill to study pharmacy benefit managers (PBMs).

DEEP DIVE

Congressional:


Senate Confirms FDA & NIH Nominees

On Tuesday, the Senate confirmed Marty Makary’s nomination as commissioner of the Food and Drug Administration (FDA) in a 56-44 vote with several Democrats joining Republicans including Senators Maggie Hassan (D-NH), Jeanne Shaheen (D-NH) and Dick Durbin (D-IL). The Senate also confirmed Jay Bhattacharya as director of the National Institutes of Health (NIH) in a 53-47 vote along party lines.

 

Senate Finance Committee Advances CMS Nominee

Also on Tuesday, the Senate Finance Committee held a markup advancing the nomination of Mehmet Oz to be Administrator of the Centers for Medicare & Medicaid Services (CMS) by a vote of 14-13 along party lines. Sen. Mike Crapo (R-ID), chair of the Senate Finance Committee, stated, "There is no doubt Dr. Oz will work tirelessly to deliver much needed change at CMS." Democrats stated that they voted against Oz because he did not unequivocally say he would protect Medicaid from cuts that House Republicans are considering as part of their reconciliation bill.

 

Senator Wyden Investigation Finds Rapid Growth in Spending on Marketing of Medicare Advantage Plans

On Tuesday, Senate Finance Committee Ranking Member Ron Wyden (D-OR) released an investigative report into the practices of third-party marketing organizations (TPMOs) that sell Medicare Advantage (MA) plans. The report recommended stronger regulations to protect consumers from deceptive MA marketing practices, including banning excessive marketing fees, prohibiting technology that limits plan visibility, and directly regulating marketing organizations and lead generators. Additional recommendations include enforcing penalties for violations, establishing fixed fees for MA enrollments, requiring agents and brokers to act in the best interests of consumers, standardizing enrollment terminology, and increasing support for unbiased information sources, such as SHIPs and 1-800-MEDICARE. Read the press release and the report here.

 

Democratic Leader Schumer and Top Budget Senate Dems Call on Senate Republicans to Commit to Protecting Medicaid

On Thursday, Democratic Leader Chuck Schumer (D-NY), Ranking Member of the Finance Committee Ron Wyden (D-OR), and Ranking Member of the Budget Committee Jeff Merkley (D-OR) sent a letter to Republican Leader John Thune (R-SD), Chairman of the Senate Budget Committee Lindsey Graham (R-SC), and Chairman of Finance Committee Mike Crapo (R-ID) asking how Senate Republicans plan to reduce the deficit in the Finance Committee’s jurisdiction by at least one billion dollars without cutting Medicaid. The letter states that cuts to Medicaid would harm seniors, veterans, children, and people with disabilities while benefiting wealthy individuals and corporations through tax breaks. The Senators urged Senate Republicans to prevent such cuts and ensure that vulnerable populations retain access to essential healthcare services. Read the press release and letter here.

 

Representatives Van Duyne and Cleaver Lead Bipartisan Group in Effort to Improve Transportation of Lifesaving Organ Donations

Late last week, Representatives Beth Van Duyne (R-TX-24) and Emanuel Cleaver (D-MO-05) led a bipartisan group of 27 lawmakers in requesting that Transportation Secretary Duffy and Acting FAA Administrator Rocheleau support the Organ Transportation Working Group, which was established by the FAA Reauthorization Act of 2024. The working group is tasked with developing recommendations for the in-cabin transportation of lifesaving donor organs to ensure patients receive them safely and efficiently. In the letter, the lawmakers encouraged the Organ Transportation Working Group to “continue developing recommendations for the in-cabin transportation of lifesaving donor organs to meet the statutory requirements for release in 2025.” Read the press release and letter here.

 

Democrats Urge Trump to Fully Fund HIV/AIDS Prevention

Late last week, Representative Mark Pocan (D-WI-02) and Robin Kelly (D-IL-02), along with Senators Kirsten Gillibrand (D-NY) and Jeff Merkley (D-OR), led a bicameral letter with 97 of their colleagues, urging President Trump to maintain the Centers for Disease Control and Prevention’s (CDC) Division of HIV Prevention. In the letter, lawmakers expressed "deep concern" over reported plans for the administration to close the Division of HIV Prevention within the National Center of HIV, Viral Hepatitis, STD, and Tuberculosis Prevention. The members also reminded Trump of his statement on ending HIV at the 2019 State of the Union address: “On February 5, 2019, you declared a commendable and ambitious goal of ending the HIV epidemic (EHE) in the United States.” The Members concluded. “Just last week, Congress passed a Continuing Resolution, which continues funding levels from Fiscal Year 2024, that appropriated funding to CDC for carrying out HIV/AIDS programs. Accordingly, we expect CDC will continue to carry out those programs.” Read the press release and letter here. 



Notable Bills Introduced:


Senators Cassidy, Booker, Cramer, Heinrich Reintroduce Bill to Protect Dialysis Patients

On Thursday, Senators Bill Cassidy, M.D. (R-LA), Cory Booker (D-NJ), Kevin Cramer (R-ND), and Martin Heinrich (D-NM), and Kevin Cramer (R-ND) reintroduced the Restore Protections for Dialysis Patients Act to ensure individuals with End Stage Renal Disease (ESRD), or kidney failure, continue to have access to private health care. Read the press release here and the bill here.

 

Senators Thune, Murphy, Kelly, Panetta Reintroduce Bill to Incentivize Healthy Living and Physical Activity

On Thursday, Senators John Thune (R-SD) and Chris Murphy (D-CT) and Representatives Mike Kelly (R-PA) and Jimmy Panetta (D-CA) reintroduced the Personal Health Investment Today (PHIT) Act. This bipartisan legislation would encourage physical activity and incentivize healthier living by allowing Americans to use a portion of the money saved in their pre-tax health savings account (HSA) and flexible spending account (FSA) toward qualified sports and fitness purchases, such as gym memberships, fitness equipment, and youth sports league fees. Read the press release here and the bill here.

 

Senators Grassley, Klobuchar Introduce Bills to Reduce Drug Costs by Promoting Competition

On Wednesday, Senate Judiciary Committee Chairman Chuck Grassley (R-IA) and Senator Amy Klobuchar (D-MN), a member of the Judiciary Committee, introduced two bipartisan bills aimed at reducing drug prices by promoting competition and addressing anti-competitive practices, including settlements and Food and Drug Administration (FDA) petitions, by drug companies. The Preserve Access to Affordable Generics and Biosimilars Act would limit patent settlements that prevent or delay the introduction of generic drugs. The Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act would deter branded pharmaceutical companies from filing “citizen petitions” with the FDA to interfere with the approval of generic and biosimilar medicines that compete with their brand products. The Senate Judiciary Committee will mark up both bills on Thursday, April 3, at 10:15 AM. Read the press release here.

 

Senators Grassley, Durbin, Colleagues Introduce Legislation to Improve Coordination between Patent Office and FDA

On Tuesday, Senate Judiciary Committee Chairman Chuck Grassley (R-IA) joined Ranking Member Dick Durbin (D-IL), along with Committee members Thom Tillis (R-NC), Peter Welch (D-VT) and Chris Coons (D-DE), to introduce the Interagency Patent Coordination and Improvement Act. The bipartisan legislation would establish a task force between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) to improve communication and coordination in implementing each agency’s activities related to pharmaceutical patents. The Senate Judiciary Committee will mark up the bill on Thursday, April 3, at 10:15 AM. Read the press release here and the bill here.

 

Senators Cassidy, Padilla Reintroduce Bill to Modernize Health Care System, Improve Access to Digital Health Services

On Wednesday, Senators Bill Cassidy (R-LA) and Alex Padilla (D-CA) reintroduced the Health Accelerating Consumers’ Care by Expediting Self-Scheduling (ACCESS) Act to improve patients’ access to modernized health care, provide certainty for patients seeking digital health services, and protect patients’ personal health information. The legislation would adjust the Anti-Kickback Statute (AKS) to remove the regulatory ambiguity, allowing digital health and appointment booking platforms to work together to better serve patients. Read the press release here and the bill here.

 

Senators Cassidy, Merkley Introduce Bill to Address Upcoding in the Medicare Advantage Program

On Tuesday, Senators Bill Cassidy, M.D. (R-LA) and Jeff Merkley (D-OR) introduced the No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act to improve the way Medicare Advantage plans assess patients’ health risks and reduce overpayments for care. The legislation would develop a risk-adjustment model that utilizes two years of diagnostic data instead of just one year, limit the use of outdated or unrelated medical conditions when determining the cost of care, and ensure that Medicare is only charged for treatment related to relevant medical conditions. Read the press release here and the bill here.

 

Representative Harshbarger Reintroduces Bipartisan FAIR Act

On Tuesday, Representatives Diana Harshbarger (R-TN), Chellie Pingree (D-ME), Sam Graves (R-MO), Carol Miller (R-WV), and Don Davis (D-NC) reintroduced the bipartisan Fair Access in Residency (FAIR) Act. This legislation seeks to ensure that taxpayer-funded physician residency training programs provide equal opportunities for both Doctors of Osteopathic Medicine (DOs) and Medical Doctors (MDs). Read the press release here and the bill here. 


Executive Branch:



HHS Announces Restructuring

On Thursday, the Department of Health and Human Services (HHS) announced a restructuring in accordance with President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” The restructuring will reduce the workforce by 10,000 full-time employees, which, when combined with HHS’s other efforts, including early retirement and Fork in the Road, will result in a total downsizing from 82,000 to 62,000 full-time employees. Secondly, it will consolidate the 28 divisions of the HHS into 15 new divisions, including a new Administration for a Healthy America (AHA), and will centralize core functions such as Human Resources, Information Technology, Procurement, External Affairs, and Policy. Regional offices will be reduced from 10 to 5. Third, the overhaul will implement the new HHS priority of ending America’s epidemic of chronic illness by focusing on “safe, wholesome food, clean water, and the elimination of environmental toxins.”

 

Of the 10,000 job cuts, the FDA will dismiss 3,500 employees, which HHS stated would “not affect drug, medical device, or food reviewers, nor will it impact inspectors.” Approximately 2,400 employees will be laid off from the CDC, which is set to merge with the Administration for Strategic Preparedness and Response. CMS will lay off 300 workers, and the NIH will lay off 1,200. Read the press release here and the fact sheet here.

 

Trump Nominates Susan Monarez to lead CDC

On Monday, President Donald Trump nominated Susan Monarez, the Centers for Disease Control’s (CDC) current acting director, to serve as the next director. The decision comes after the administration pulled the first nominee, Dr. Dave Weldon, hours before his Senate confirmation hearing. Before joining the CDC earlier this year, Monarez was deputy director for the Advanced Research Projects Agency for Health (ARPA-H). Trump posted the announcement on Truth Social, highlighting Monarez's experience in public health. "Dr. Monarez will work closely with our GREAT Secretary of Health and Human Services, Robert Kennedy Jr. Together, they will prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and MAKE AMERICA HEALTHY AGAIN!" Trump wrote.

 

HHS Continues Grant Terminations

On Sunday, the Department of Health and Human Services (HHS) published an updated list of spending cuts, which shows grants canceled between February 20 and March 20, including dozens devoted to HIV research and others related to chronic diseases. As of March 21, HHS had canceled more than 250 grants, mainly to universities. Many of the grants appeared to mention gender, sexuality, or diversity. During a Monday cabinet meeting, HHS Secretary Robert F. Kennedy Jr. praised billionaire Elon Musk’s Department of Government Efficiency for cutting spending in his agency, including staff, stating, “We are, with Elon’s help, eliminating the redundancy. We are streamlining our department.” “We’re going to get the money to the scientists and to the patients,” Kennedy added. See the list of terminated grants here.

 

CDC Reschedules Vaccine Advisory Panel Meeting

On Monday, the Centers for Disease Control and Prevention (CDC) announced plans to reschedule its vaccine advisory panel meeting, which was postponed earlier this year. The CDC's Advisory Committee on Immunization Practices (ACIP) was initially scheduled to meet on February 26 to 28 to discuss and vote on recommendations for meningococcal vaccines, Chikungunya vaccines, influenza vaccines, and RSV vaccines. The new meeting is scheduled to take place online on April 15 and 16. The announcement states that the committee will vote on recommendations for meningococcal vaccines, Chikungunya vaccines, and RSV vaccines for adults; however, the influenza vaccine is absent from the list of votes. The FDA’s Vaccines and Related Biological Products Advisory Committee meeting, scheduled to discuss and make a recommendation for the updated flu vaccine, was abruptly canceled earlier this month. However, the FDA made a recommendation without consulting the panel. See the meeting agenda here.

 

HHS to Close Office of Long COVID Research and Practice

On Monday, the Department of Health and Human Services (HHS) announced in an internal email that the administration is closing HHS' Office of Long COVID Research and Practice. The email from the director of the office, Ian Simon, stated, “We are writing to let you know that the Office of Long COVID Research and Practice will be closing as part of the administration’s reorganization coming this week.” The email stated that the closing is part of HHS's reorganization but did not specify whether the office would close immediately or wind down its operations over time.

CONGRESSIONAL HEARINGS & EVENTS

House:


House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations – Hearing

“Aging Technology, Emerging Threats: Examining Cybersecurity Vulnerabilities in Legacy Medical Devices”

Tuesday, April 1, at 10:30 AM.

 

House Committee on Energy and Commerce, Subcommittee on Health – Hearing

“Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs”

Tuesday, April 1, at 10:15 AM.

 

House Committee on Education and Workforce, Subcommittee on Health, Employment, Labor, and Pensions - Hearing

"A Healthy Workforce: Expanding Access and Affordability in Employer-Sponsored Health Care"

Wednesday, April 2, at 2:00 PM


Senate:


Senate Judiciary Committee – Markup

“To markup S. 527, Prescription Pricing for the People Act of 2025; S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes; S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes; S. 1097, Interagency Patent Coordination and Improvement Act of 2025; S. 1095, Stop STALLING Act; and S. 1096, Preserve Access to Affordable Generics and Biosimilars Act”

Thursday, April 3, at 10:15 AM

ADMINISTRATION ANNOUNCEMENTS

Centers for Medicare & Medicaid Services

Food and Drug Administration

National Institutes of Health

1341 G Street NW
Washington, DC 20005
202-585-0258